샘플 요청 목록

 카트 문의
시장보고서
상품코드
1773978

세계의 지주막낭종 치료 시장

Arachnoid Cysts Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 462 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

지주막낭종 치료 세계 시장은 2030년까지 17억 달러에 달할 전망

2024년에 13억 달러로 추정되는 지주막낭종 치료 세계 시장은 2030년에는 17억 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 3.8%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 두개내 지주막낭종은 CAGR 3.1%를 기록하며 분석 기간 종료까지 11억 달러에 달할 것으로 예측됩니다. 척수 지주막낭종 부문의 성장률은 분석 기간 동안 CAGR 5.2%로 추정됩니다.

미국 시장은 3억 6,320만 달러로 추정, 중국은 CAGR 6.9%로 성장 예측

미국의 지주막낭종 치료 시장은 2024년에 3억 6,320만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 6.9%를 기록하며 2030년에는 예측 시장 규모 3억 3,380만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.6%와 2.9%로 예측됩니다. 유럽에서는 독일이 CAGR 2.2%로 성장할 것으로 예측됩니다.

세계의 지주막낭종 치료 시장 - 주요 동향과 촉진요인 정리

지주막낭종이란 무엇인가?

지주막낭종은 뇌와 척수와 중추신경계를 둘러싸고 있는 세 개의 보호막 중 하나인 거미막 사이에 발생하는 액체로 채워진 낭종입니다. 이러한 낭종은 선천적인 경우가 많지만, 외상이나 감염, 뇌수술의 합병증으로 발생하기도 합니다. 대부분의 지주막낭종은 무증상인 경우가 많아 영상 검사에서 우연히 발견되지만, 증상이 있는 경우 두통, 어지럼증, 경련, 수두증, 인지장애 등의 신경학적 합병증을 유발할 수 있습니다. 자기공명영상법(MRI), 컴퓨터단층촬영(CT), 뇌척수액 흐름검사 등 영상 진단 기술의 발전으로 뇌척수낭종의 발견과 특징이 크게 개선되었습니다. 또한, 고해상도 영상 진단 도구의 사용으로 조기 진단 및 치료 계획이 가능해져 장기적인 합병증 위험을 줄일 수 있게 되었습니다. 또한, 인공지능(AI) 기반 방사선 진단 솔루션은 낭종 분류의 정확도를 향상시켜 증상성 낭종과 우발성 낭종을 구분할 수 있도록 돕습니다. 의료진이 진단 프로토콜을 지속적으로 개선함에 따라, 뇌하수체 낭종 관리에서 치료 결정을 안내하는 정밀 영상의 역할이 점점 더 중요해지고 있습니다.

지주막낭종 치료의 수술적, 비수술적 접근법은 어떻게 발전하고 있는가?

뇌하수체 낭종의 치료는 증상의 심각성, 낭종의 크기, 부위에 따라 달라집니다. 무증상 낭종은 대부분 치료가 필요하지 않지만, 증상이 있는 경우에는 비수술적 관리 또는 수술적 치료가 필요합니다. 경증의 경우 진통제, 항경련제, 코르티코스테로이드와 같은 약리학적 치료로 증상을 조절할 수 있습니다. 그러나 진행성 신경장애, 수두증, 두개내압항진증이 있는 환자에게는 수술적 치료가 필요한 경우가 많습니다. 신경외과 기술의 발전은 지주막낭종 치료에 혁명을 가져왔으며, 내시경적 격자형 절제술, 방광복강 션트술, 미세수술적 절제술 등의 최소침습적 수술이 각광받고 있습니다. 특히, 내시경적 방광요관절제술은 합병증 위험 감소, 회복 시간 단축, 수술 후 예후 개선으로 인해 선호되는 수술법으로 떠오르고 있습니다. 또한, 수술 중 신경 탐색과 실시간 이미지의 통합으로 수술 정확도가 향상되고 주변 뇌 구조에 대한 손상을 최소화할 수 있습니다. 로봇 보조 뇌수술의 채택이 확대됨에 따라 손재주, 수술 시간 단축, 환자 안전성이 향상되어 치료 방법이 더욱 변화하고 있습니다. 수술의 혁신이 계속 발전함에 따라 신경외과 의사들은 지주막낭종 환자의 결과를 최적화하기 위해 개별화된 접근법을 채택하고 있습니다.

지주막낭종 치료 수요에 영향을 미치는 시장 동향은 무엇인가?

신경질환 발생률 증가, 신경외과 연구에 대한 투자 증가, 정밀의료의 발전 등 여러 시장 동향이 지주막낭종 치료에 대한 수요를 형성하고 있습니다. 간질, 수두증, 외상성 뇌손상 등 신경 질환의 세계적 유행으로 인해 지주막낭종에 대한 조기 개입과 첨단 치료 전략에 대한 관심이 높아지고 있습니다. 또한, 신경과 및 신경외과 전문 센터의 확장으로 양질의 치료에 대한 접근성이 향상되어 더 많은 환자들이 최첨단 치료법의 혜택을 누릴 수 있게 되었습니다. 또한, 환자 중심 의료에 대한 관심이 높아지면서 비침습적, 최소침습적 치료 접근법에 대한 수요가 증가하고 있으며, 의료기기 제조업체들은 혁신적인 수술 도구와 신경 내비게이션 시스템 개발을 촉진하고 있습니다. 또한, 신경외과 수술 계획에 AI와 머신러닝을 통합하여 예측 분석과 실시간 의사결정을 가능하게함으로써 치료 결과를 최적화하고 있습니다. 신경학적 건강에 대한 인식이 높아지고 의료 기술이 발전함에 따라, 뇌척수낭종 치료 환경은 환자와 의료진의 요구를 충족시키기 위해 빠르게 진화하고 있습니다.

지주막낭종 치료 시장을 촉진하는 주요 성장 요인은 무엇인가?

지주막낭종 치료 시장의 성장은 신경외과 수술의 기술 발전, AI를 활용한 진단 방법의 채택 증가, 최소침습적 치료에 대한 환자 선호도 증가 등 여러 요인에 의해 주도되고 있습니다. 내시경 및 로봇 보조 신경외과 수술의 지속적인 개발로 치료 효과가 향상되고, 수술 위험이 감소하며, 회복 시간이 개선되고 있습니다. 또한, 원격의료 및 원격진료 서비스의 이용이 가능해짐에 따라, 특히 의료 인프라가 제한적인 지역에서는 신경외과 전문 지식에 대한 접근성이 확대되고 있습니다. 또한, 의료비 증가와 신경학 연구에 대한 정부의 재정 지원도 새로운 치료 전략과 차세대 의료기기 개발을 지원하며 시장 확대에 박차를 가하고 있습니다. 또한, 제약사, 의료기술 기업, 연구기관 간의 협력 관계의 증가는 뇌척수낭종 관리를 위한 혁신적인 치료법 개발을 가속화하고 있습니다. 정밀의료와 맞춤형 치료 계획에 대한 수요가 지속적으로 증가함에 따라 의학의 발전, 진화하는 의료 정책, 환자 결과 개선에 대한 관심 증가로 인해 뇌척수낭종 치료 시장은 지속적으로 성장할 것으로 예상됩니다.

부문

유형(두개내 지주막낭종, 척수 지주막낭종), 진단(CT 스캔, MRI 스캔, 출생전 초음파 검사, 기타 진단), 치료 유형(내시경 낭종 천공술, 천공술, 영구 배액 시스템 수술), 최종사용자(병원 최종사용자, 외래 수술 센터 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • Abbott Laboratories
  • Accuray Incorporated
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Elekta AB
  • GE Healthcare
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Novartis AG
  • Olympus Corporation
  • Penumbra, Inc.
  • Pfizer Inc.
  • Philips Healthcare
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Varian Medical Systems, Inc.
  • Zimmer Biomet Holdings, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.28

Global Arachnoid Cysts Treatment Market to Reach US$1.7 Billion by 2030

The global market for Arachnoid Cysts Treatment estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Intracranial Arachnoid Cysts, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Spinal Arachnoid Cysts segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$363.2 Million While China is Forecast to Grow at 6.9% CAGR

The Arachnoid Cysts Treatment market in the U.S. is estimated at US$363.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$333.8 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Arachnoid Cysts Treatment Market - Key Trends & Drivers Summarized

What Are Arachnoid Cysts and How Are They Diagnosed?

Arachnoid cysts are fluid-filled sacs that develop between the brain or spinal cord and the arachnoid membrane, one of the three protective layers surrounding the central nervous system. These cysts are often congenital but can also arise due to trauma, infections, or complications from brain surgeries. While many arachnoid cysts remain asymptomatic and are discovered incidentally during imaging tests, symptomatic cases can lead to neurological complications, including headaches, dizziness, seizures, hydrocephalus, and cognitive impairment. Advances in diagnostic imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and cerebrospinal fluid flow studies have significantly improved the detection and characterization of arachnoid cysts. The increasing availability of high-resolution imaging tools has also enabled early diagnosis and treatment planning, reducing the risk of long-term complications. Furthermore, artificial intelligence (AI)-powered radiology solutions are enhancing the accuracy of cyst classification, allowing for better differentiation between symptomatic and incidental cysts. As healthcare providers continue to refine diagnostic protocols, the role of precision imaging in guiding treatment decisions is becoming increasingly critical in the management of arachnoid cysts.

How Are Surgical and Non-Surgical Approaches Evolving in Arachnoid Cyst Treatment?

The treatment of arachnoid cysts varies based on the severity of symptoms, cyst size, and location. While asymptomatic cysts often require no intervention, symptomatic cases may necessitate either non-surgical management or surgical procedures. Pharmacological treatments, including pain relievers, anti-seizure medications, and corticosteroids, are commonly used for symptom management in mild cases. However, for patients experiencing progressive neurological deficits, hydrocephalus, or increased intracranial pressure, surgical intervention is often required. Advances in neurosurgical techniques have revolutionized the treatment of arachnoid cysts, with minimally invasive procedures such as endoscopic fenestration, cystoperitoneal shunting, and microsurgical resection gaining prominence. Endoscopic fenestration, in particular, has emerged as a preferred approach due to its reduced risk of complications, shorter recovery times, and improved postoperative outcomes. Additionally, the integration of intraoperative neuro-navigation and real-time imaging has enhanced surgical precision, minimizing damage to surrounding brain structures. The growing adoption of robotic-assisted neurosurgery is further transforming treatment modalities, offering greater dexterity, reduced operative time, and enhanced patient safety. As surgical innovations continue to evolve, neurosurgeons are increasingly adopting personalized approaches to optimize outcomes for patients with arachnoid cysts.

What Market Trends Are Influencing the Demand for Arachnoid Cyst Treatments?

Several market trends are shaping the demand for arachnoid cyst treatments, including the rising incidence of neurological disorders, increasing investments in neurosurgical research, and advancements in precision medicine. The global prevalence of neurological conditions such as epilepsy, hydrocephalus, and traumatic brain injuries has heightened the focus on early intervention and advanced treatment strategies for arachnoid cysts. Additionally, the expansion of specialized neurology and neurosurgery centers has improved access to high-quality care, enabling more patients to benefit from cutting-edge treatment options. The growing emphasis on patient-centric healthcare is also driving demand for non-invasive and minimally invasive therapeutic approaches, prompting medical device manufacturers to develop innovative surgical instruments and neuro-navigation systems. Furthermore, the integration of AI and machine learning in neurosurgical planning is optimizing treatment outcomes by enabling predictive analytics and real-time decision-making. With increasing awareness of neurological health and advancements in medical technology, the landscape of arachnoid cyst treatment is rapidly evolving to meet the needs of patients and healthcare providers alike.

What Are the Key Growth Drivers Fueling the Arachnoid Cyst Treatment Market?

The growth in the arachnoid cyst treatment market is driven by several factors, including technological advancements in neurosurgical procedures, the rising adoption of AI-powered diagnostics, and increasing patient preference for minimally invasive treatments. The continuous development of endoscopic and robotic-assisted neurosurgery is enhancing treatment efficacy, reducing surgical risks, and improving recovery times. Additionally, the increasing availability of telemedicine and remote consultation services is expanding access to neurosurgical expertise, particularly in regions with limited healthcare infrastructure. The rising healthcare expenditure and government funding for neurological research are also fueling market expansion by supporting the development of novel treatment strategies and next-generation medical devices. Furthermore, growing collaborations between pharmaceutical companies, medical technology firms, and research institutions are accelerating the development of innovative therapies for arachnoid cyst management. As the demand for precision medicine and personalized treatment plans continues to rise, the arachnoid cyst treatment market is expected to experience sustained growth, driven by medical advancements, evolving healthcare policies, and the increasing focus on improving patient outcomes.

SCOPE OF STUDY:

The report analyzes the Arachnoid Cysts Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Intracranial Arachnoid Cysts, Spinal Arachnoid Cysts); Diagnosis (CT Scan, MRI Scan, Prenatal Ultrasound, Other Diagnosis); Treatment Type (Endoscopic Cysts Fenestration, Fenestration, Permanent Drainage System Surgery); End-Use (Hospital End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • Accuray Incorporated
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Elekta AB
  • GE Healthcare
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Novartis AG
  • Olympus Corporation
  • Penumbra, Inc.
  • Pfizer Inc.
  • Philips Healthcare
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Varian Medical Systems, Inc.
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Arachnoid Cysts Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Detection of Incidental Brain Cysts Due to Increased MRI Usage Expands Diagnostic Rate for Arachnoid Cysts
    • Advancements in Neuroimaging Techniques Strengthen Accuracy in Arachnoid Cyst Localization and Characterization
    • Surge in Pediatric Neurology Referrals Throws the Spotlight on Early Intervention and Monitoring of Arachnoid Cysts
    • Increasing Adoption of Minimally Invasive Neurosurgical Techniques Drives Surgical Treatment Uptake
    • Growth in Neurosurgical Navigation and Real-Time Imaging Supports Safe Resection and Drainage Procedures
    • Rising Prevalence of Symptomatic Arachnoid Cysts With Neurological Deficits Fuels Therapeutic Intervention Demand
    • Expansion of Specialized Neurosurgical Centers and Pediatric Neurology Clinics Improves Access to Treatment
    • Increased Use of Endoscopic Fenestration Procedures Enhances Recovery Outcomes and Reduces Hospital Stay
    • Development of Biocompatible Shunt Systems Strengthens Business Case for CSF Diversion Therapies
    • Greater Awareness Among General Practitioners and Pediatricians Promotes Timely Referrals and Screening
    • Emerging Research Into Genetic and Developmental Causes Supports Long-Term Surveillance Protocols
    • Adoption of Personalized Neurosurgical Planning With 3D Imaging and Patient-Specific Simulations Improves Outcomes
    • Advancements in Intraoperative Monitoring and Brain Mapping Tools Enhance Surgical Precision
    • Improved Post-Surgical Rehabilitation Protocols Sustain Quality of Life Post-Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Arachnoid Cysts Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Arachnoid Cysts Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Intracranial Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Intracranial Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Intracranial Arachnoid Cysts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spinal Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spinal Arachnoid Cysts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spinal Arachnoid Cysts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for MRI Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for MRI Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for MRI Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Prenatal Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Prenatal Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Prenatal Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Endoscopic Cysts Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Endoscopic Cysts Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Endoscopic Cysts Fenestration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fenestration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Fenestration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Permanent Drainage System Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Permanent Drainage System Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Permanent Drainage System Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • JAPAN
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • CHINA
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • EUROPE
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Arachnoid Cysts Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • FRANCE
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • GERMANY
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • INDIA
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Arachnoid Cysts Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Arachnoid Cysts Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030
  • AFRICA
    • Arachnoid Cysts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Arachnoid Cysts Treatment by Type - Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Arachnoid Cysts Treatment by Type - Percentage Breakdown of Value Sales for Intracranial Arachnoid Cysts and Spinal Arachnoid Cysts for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Arachnoid Cysts Treatment by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Arachnoid Cysts Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Arachnoid Cysts Treatment by Diagnosis - CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Arachnoid Cysts Treatment by Diagnosis - Percentage Breakdown of Value Sales for CT Scan, MRI Scan, Prenatal Ultrasound and Other Diagnosis for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Arachnoid Cysts Treatment by Treatment Type - Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Arachnoid Cysts Treatment by Treatment Type - Percentage Breakdown of Value Sales for Endoscopic Cysts Fenestration, Fenestration and Permanent Drainage System Surgery for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제